FindTrial
Sign In

A Study on Individualized Homeopathy in the Management of Fungal Skin Diseases

UTILITY OF INDIVISUALIZED HOMOEOPATHIC MEDICINE IN DERMATOPHYTOSIS WITH MIASMATIC ANALYSIS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103418
Enrollment
30
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: Indivisualized Homoeopathic Medicine: Patients qualifying to inclusion criteria will be included in the study. Proper case taking of all enrolled patients will be done. Homoeopathic med

Sponsors

Dr Shweta Pandey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from dermatophytes such as tinea corporis, tinea capitis, tinea unguinum and tinea cruris. 2. Literate patients; ability to read English/ Hindi. 3. Patients providing written informed consent. 4. Patient using antifungal agents will be included after a washout period of two weeks.

Exclusion criteria

Exclusion criteria: 1. Cases with complication like lichenification and eczematisation. 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and Psoriasis and any other fungal infection such as candidiasis, cutaneous aspergillosis. 3. Patients who are too sick for consultation and unwilling to take part or not giving consent to join the study. 4.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 5. Pregnant women and lactating mothers. 6. Substance abuse and/or dependence. 7.Self-reported immune-compromised state. 8. Already undergoing homeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of indivisualized homoeopathic medicine with miasmatic analysis showing improvement in clinical features before and after treatment.Timepoint: 30 days—

Secondary

MeasureTime frame
To evaluate the effect of indivisualized homoeopathic medicine with miasmatic analysis showing improvement in clinical presentation using DLQI before and after treatment.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Shweta Pandey

State National Homoeopathic Medical College And Hospital Gomti Nagar Lucknow

iffat.vroom@gmail.com8604062779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026